A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2011
11/09/2011	EP2385035A1 Preparation method of dihydroindene amide compounds their pharmaceutical compositions containg compounds thereof and use as protein kinases inhibitor
11/09/2011	EP2385032A1 GPR40 Receptor function regulator
11/09/2011	EP2384791A2 Method and composition for treating mucosal disorders
11/09/2011	EP2384790A2 Method and composition for treating mucosal disorders
11/09/2011	EP2384768A1 Phenylpropionamide compounds and the use thereof
11/09/2011	EP2384760A1 Sulphated hyaluronic acid in combination with G-CSF for use in mobilising blood stem cells
11/09/2011	EP2384759A1 Sulphated hyaluronic acid in combination with G-CSF for use in mobilising blood stem cells
11/09/2011	EP2384758A1 Polyacetylenic compounds
11/09/2011	EP2384757A1 Prevention and/ortreatment of neurodegenerative disorders
11/09/2011	EP2384756A2 High-purity large-scale preparation of stannsoporfin
11/09/2011	EP2384755A1 Eslicarbazepine acetate and methods of use
11/09/2011	EP2384754A1 Pharmaceutical dosage forms
11/09/2011	EP2384753A1 Hydantoin derivatives as inhibitors of cellular necrosis
11/09/2011	EP2384752A1 Combination preparation comprising a phosphodiesterase inhibitor and a COX inhibitor for treating cancer
11/09/2011	EP2384751A1 Medicaments for the treatment or prevention of fibrotic diseases
11/09/2011	EP2384750A1 Improved Glycemic Control for Prediabetes and/or Diabetes Type II using Docohexaenoic Acid
11/09/2011	EP2384749A1 Dosage regimen of an S1P receptor agonist
11/09/2011	EP2384747A2 Oral Tablet Compositions Of Dexlansoprazole
11/09/2011	EP2384746A2 Dual release oral tablet compositions of dexlansoprazole
11/09/2011	EP2384745A2 Modified Release Pharmaceutical Compositions Of Dexlansoprazole
11/09/2011	EP2384743A1 Siosomal formulation for intracellular delivery and targeting of therapeutic agents
11/09/2011	EP2384741A2 Topical product
11/09/2011	EP2384740A2 Oral care product and methods of use and manufacture thereof
11/09/2011	EP2384739A2 Oral care product and methods of use and manufacture thereof
11/09/2011	EP2384648A1 New compositions containing omega 3 and usage to treat hangover
11/09/2011	EP2384623A1 Powder composition for the prevention and treatment of animal hoof diseases
11/09/2011	EP2384333A1 Anti-inflammatory macrolide
11/09/2011	EP2384332A1 9-deoxo- 9a-methyl- 9a- aza- 9a-h0m0erythr0mycin a derivatives for the treatment of neutrophil dominated inflammatory diseases
11/09/2011	EP2384328A1 6,7,8,9-tetrahydro-5h-1,4,7,10a-tetraaza-cyclohept[f]indene derivatives, pharmaceutical compositions containing these compounds, their use and process for preparing them
11/09/2011	EP2384327A1 Fused ring compound and use thereof
11/09/2011	EP2384326A1 Pyrrolo[2,3-d]pyrimidine compounds
11/09/2011	EP2384320A2 Pyrrolidine compounds which modulate the cb2 receptor
11/09/2011	EP2384318A2 Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
11/09/2011	EP2384198A2 Pharmaceutical compositions and methods of treating neurological insults
11/09/2011	EP2384197A1 Use of lna apob antisense oligomers for the treatment of acute coronary syndromes
11/09/2011	EP2384196A2 Methods of identifying critically ill patients at increased risk of development of organ failure and compounds for the treatment hereof
11/09/2011	EP2384195A1 Cosmetic use of 1-aroyl-n-(2-oxo-3-piperidinyl)-2-piperazine carboxamides and related compounds
11/09/2011	EP2384194A1 5-ht4 inhibitors for treating airway diseases, in particular asthma
11/09/2011	EP2384193A2 Vitamin d promoting sunscreen
11/09/2011	EP2384192A1 Biological oil composition, formulations comprising the oil composition, and use thereof to prevent or treat cardiovascular disease
11/09/2011	EP2384191A1 Diene compounds for use in human epidermal cell repair, and pharmaceutical and cosmetic compositions containing them
11/09/2011	EP2384188A1 Pharmaceutical microemulsion for preventing supramolecular aggregation of amphiphilic molecules
11/09/2011	EP2384184A2 Personal care article for sequentially dispensing compositions with variable concentrations of hydrophobic benefit materials
11/09/2011	EP2384120A1 Adjuvant compositions and methods of use
11/09/2011	EP2384119A1 Pharmaceutical composition comprising racemic aminopterin
11/09/2011	EP2384118A1 Sphingo-guanidines and their use as inhibitors of sphingosine kinase
11/09/2011	EP2384115A1 Methods and compositions for treating hematological malignancies
11/09/2011	EP2384114A1 Nutraceuticals containing nitro fatty acids
11/09/2011	EP2384113A1 A composition comprising nor-adrenaline and amphetamine for administering to a brain-dead, heart -beating potential organ donor
11/09/2011	EP2384112A1 A composition comprising nor-adrenaline and a net inhibitor for administering to a brain-dead, heart-beating potential organ donor.
11/09/2011	EP2200600B1 Neramexane for use in the treatment of sub-acute tinnitus
11/09/2011	EP2146713B1 Use of 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide for the treatment of cranial traumas
11/09/2011	EP2139881B1 Quinolines and their therapeutic use
11/09/2011	EP2131843B1 Process for the synthesis of glyt-1 inhibitors
11/09/2011	EP2078022B1 Spiro benzazepines used as vasopressin antagonists
11/09/2011	EP2069353B1 Polycyclic agents for the treatment of respiratory syncytial virus infections
11/09/2011	EP2068873B1 Isoniazid mediated healing of wounds and ulcers
11/09/2011	EP2066647B1 Benzoxazoles and oxazolopyridines being useful as janus kinases inhibitors
11/09/2011	EP2054418B1 Dihydrothieno pyrimidines as akt protein kinase inhibitors
11/09/2011	EP2035001B1 Stable laquinimod preparations
11/09/2011	EP2018383B1 Triazolopyrazine derivatives useful as anti-cancer agents
11/09/2011	EP2010189B1 Osmotic drug delivery system comprising release enhancing agent
11/09/2011	EP1987030B1 3 -deazapurine derivatives as tlr7 modulators
11/09/2011	EP1982721B1 Method of stabilizing s-adenosyl-l-methionine and stabilized composition
11/09/2011	EP1978959B1 Piperidine and piperazine derivatives
11/09/2011	EP1976531B1 Irradiated compositions and treatment of cancers with radiation in combination with taurolidine and/or taurultam
11/09/2011	EP1942898B1 Dipeptidyl peptidase inhibitors for treating diabetes
11/09/2011	EP1940372B1 Novel aromatic compounds and their use in medical applications
11/09/2011	EP1899330B9 Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect
11/09/2011	EP1890709B1 Production of glucosamine from plant species
11/09/2011	EP1845964B1 Antimicrobial compositions comprising a jasmonic acid compound as active agent
11/09/2011	EP1813623B1 Purinenucleoside derivative modified in 8-position and medicinal use thereof
11/09/2011	EP1807090B9 Process for the preparation of ibandronate
11/09/2011	EP1794141B1 Substituted chroman derivatives, medicaments and use in therapy
11/09/2011	EP1789390B1 Pyridyl inhibitors of hedgehog signalling
11/09/2011	EP1789021B1 Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof
11/09/2011	EP1786812B1 Pyridine methylene azolidinones and their use as phosphoinositide inhibitors
11/09/2011	EP1773452B1 Lysis / resealing process for incorporating an active ingredient in erythrocytes
11/09/2011	EP1693451B1 Method of growing myocardial cells
11/09/2011	EP1689405B1 Thioridazine and derivatives thereof for reversing anti-microbial drug-resistance
11/09/2011	EP1673085B1 C-met modulators and methods of use
11/09/2011	EP1669450B1 Staple type oligonucleotide and drug comprising the same
11/09/2011	EP1667675B1 Entry inhibitors of the hiv virus
11/09/2011	EP1663103B1 Compositions of botanical extracts for cancer therapy
11/09/2011	EP1658263B9 Novel aminobenzophenone compounds
11/09/2011	EP1651620B1 Piperazine derivatives and their use as therapeutic agents
11/09/2011	EP1641468B1 Methods of screening pharmaceuticals for the treatment of pain
11/09/2011	EP1633740B1 5-(acylamino)indazole derivatives as kinase inhibitors
11/09/2011	EP1583529B1 Amino acid phenoxy ethers, their preparation and uses
11/09/2011	EP1542700B1 Zoledronic acid for preventing or reducing secondary fractures after hip fracture
11/09/2011	EP1526862B1 Simmondsin for use as an angiogenesis inhibitor
11/09/2011	EP1383516B1 Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
11/09/2011	EP1370539B1 Hiv inhibiting n-aminoimidazole derivatives
11/09/2011	EP1343508B1 Use of an oestrogen in the manufacture of a composition containing oestrogen for the treatment of atrophic vaginitis
11/09/2011	EP1328624B1 B7-like molecules and uses thereof
11/09/2011	EP0917588B2 Method for preparing a polydispersed saccharide composition and resulting polydispersed saccharide composition
11/09/2011	CN1980693B P. gingivalis vaccine
11/09/2011	CN1946456B Alcohol metabolism moderating composition
11/09/2011	CN1938309B CRF receptor antagonists and methods relating thereto
11/09/2011	CN1935818B Adefovir dipivoxil novel crystallinestate, crystalline state composition, and its preparing method and use

1 ... 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 1509 ... 7860